Cargando…
Combination of Oligofructose and Metformin Alters the Gut Microbiota and Improves Metabolic Profiles, Contributing to the Potentiated Therapeutic Effects on Diet-Induced Obese Animals
Accumulating studies implicate that the metformin (MET)- and oligofructose (OFS)-altered gut microbiota may play roles in the improvement of type 2 diabetes mellitus (T2DM) and obesity. However, whether the combined administration of OFS and MET could effectively affect the gut microbiota and improv...
Autores principales: | Li, Qingzhong, He, Rui, Zhang, Fengmei, Zhang, Jian, Lian, Shihai, Liu, Hongxia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052043/ https://www.ncbi.nlm.nih.gov/pubmed/32158428 http://dx.doi.org/10.3389/fendo.2019.00939 |
Ejemplares similares
-
Prebiotic oligofructose protects against high-fat diet-induced obesity by changing the gut microbiota, intestinal mucus production, glycosylation and secretion
por: Paone, Paola, et al.
Publicado: (2022) -
The critical role of gut microbiota in obesity
por: Cheng, Zilu, et al.
Publicado: (2022) -
Altered Gut Microbiota in Children With Hyperuricemia
por: Yuan, Xin, et al.
Publicado: (2022) -
Effect of Metformin on Short-Term High-Fat Diet-Induced Weight Gain and Anxiety-Like Behavior and the Gut Microbiota
por: Ji, Shuqin, et al.
Publicado: (2019) -
Ovariectomy Impaired Hepatic Glucose and Lipid Homeostasis and Altered the Gut Microbiota in Mice With Different Diets
por: Lei, Zili, et al.
Publicado: (2021)